Free Trial
NASDAQ:OSUR

OraSure Technologies Q3 2026 Earnings Date & Estimates

OraSure Technologies logo
$3.44 +0.07 (+2.08%)
Closing price 11/6/2026 04:00 PM Eastern
Extended Trading
$3.44 +0.00 (+0.15%)
As of 11/6/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OraSure Technologies is estimated to report Q3 2026 earnings on Monday, November 9, 2026, after market closes. The conference call is scheduled for 5:00 PM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
5:00 PM ET

What Analysts Expect from OraSure Technologies in Q3 2026

OraSure Technologies is expected to post earnings of -$0.18 per share on revenue of $31 million. In the same quarter a year earlier OraSure Technologies reported -$0.13 per share on revenue of $27.09 million. OraSure Technologies last reported on February 25, 2026, posting -$0.19 per share and missing the -$0.17 consensus estimate. OraSure Technologies has beaten the consensus EPS estimate in 5 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.18
Expected Revenue
$31 million
Prior-Year EPS
-$0.13
Prior-Year Revenue
$27.09 million
Expected Revenue Growth
+14.5%

Recent Track Record

Last Reported
Q4 2025
Last Quarter EPS
-$0.19 (Missed by -$0.02)
Last Quarter Revenue
$26.76 million
EPS Beat Rate
5 of last 8 quarters

OraSure Technologies Q3 2026 Earnings FAQ

OraSure Technologies (NASDAQ:OSUR) is estimated to report Q3 2026 earnings on Monday, November 9, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

OraSure Technologies' Q3 2026 earnings conference call is scheduled for Monday, November 9, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect OraSure Technologies to post earnings of -$0.18 per share for Q3 2026.

The consensus revenue estimate for OraSure Technologies is $31 million for Q3 2026.

OraSure Technologies Earnings Headlines

A free stock pick, from me to you
Elon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.tc pixel
See More OraSure Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like OraSure Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OraSure Technologies and other key companies, straight to your email.

About OraSure Technologies

OraSure Technologies (NASDAQ:OSUR) develops, manufactures and markets diagnostic products and specimen-collection technologies used by healthcare providers, laboratories, researchers and consumers. The company focuses on making testing more accessible through products that support decentralized, point-of-care and at-home testing, as well as laboratory-based molecular and diagnostic workflows.

Its portfolio has included the OraQuick line of rapid diagnostic tests, including oral-fluid tests for HIV and hepatitis C, along with other infectious-disease testing products. OraSure also provides oral-fluid and other specimen-collection devices, preservation systems and related laboratory solutions. Through its DNA Genotek business, the company supplies collection kits and stabilization technologies used in genomics, biobanking, clinical research and molecular testing.

OraSure serves customers in the United States and international markets through direct sales, distributors, commercial partners, government programs and online channels. Its products are used across public health, clinical care, pharmaceutical research, consumer health and academic research. The company is headquartered in Bethlehem, Pennsylvania, and has built its business around expanding access to diagnostic testing and improving the collection and analysis of biological samples.

View OraSure Technologies Profile